EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
Sara Charmsaz(QIMR Berghofer Medical Research Institute), Andy Boyd(The University of Texas at San Antonio Health Science Center)
Cited by 23